Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Hoekstra

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161Andrew T Nishimoto, Sarah G Whaley, Nathan P Wiederhold, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human EnzymeAndrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Bridged bicyclic vasopressin receptor antagonists with V(2)-selective or dual V(1a)/V(2) activityAlexey B Dyatkin, William J Hoekstra, Dennis J Hlasta, et al.
Journal of Combinatorial Chemistry|January 9, 2007
Design and synthesis of an array of selective androgen receptor modulatorsRyan P Trump, Jean-Baptiste E Blanc, Eugene L Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2005
Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonistsDavid G Jones, Xi Liang, Eugene L Stewart, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2017
VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicansTimothy J Break, Jigar V Desai, Mukil Natarajan, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51Andrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
<i>In Vitro</i> Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of <i>Candida albicans</i>Andrew T Nishimoto, Nathan P Wiederhold, Stephanie A Flowers, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|September 16, 2015
VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Nathan P Wiederhold, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161Andrew T Nishimoto, Sarah G Whaley, Nathan P Wiederhold, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human EnzymeAndrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Bridged bicyclic vasopressin receptor antagonists with V(2)-selective or dual V(1a)/V(2) activityAlexey B Dyatkin, William J Hoekstra, Dennis J Hlasta, et al.
Journal of Combinatorial Chemistry|January 9, 2007
Design and synthesis of an array of selective androgen receptor modulatorsRyan P Trump, Jean-Baptiste E Blanc, Eugene L Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2005
Discovery of non-steroidal mifepristone mimetics: pyrazoline-based PR antagonistsDavid G Jones, Xi Liang, Eugene L Stewart, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2017
VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicansTimothy J Break, Jigar V Desai, Mukil Natarajan, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51Andrew G S Warrilow, Josie E Parker, Claire L Price, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
<i>In Vitro</i> Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of <i>Candida albicans</i>Andrew T Nishimoto, Nathan P Wiederhold, Stephanie A Flowers, et al.
Pageof 4